Risk Factors for Pericardial Effusion in Inoperable Esophageal Cancer Patients Treated With Definitive Chemoradiation Therapy

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 3, 2008, Pages 707-714

  Wei, Xiong ^a   Liu, H Helen ^a   Tucker, Susan L ^a   Wang, Shulian ^b   Mohan, Radhe ^a   Cox, James D ^a   Komaki, Ritsuko ^a   Liao, Zhongxing ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b CANCER HOSPITAL   (China)

Author keywords

Concurrent chemotherapy; Dose volume of pericardium and heart; Esophageal cancer; Pericardial effusion; Three dimensional conformal radiotherapy

Indexed keywords

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; DOSIMETRY; ONCOLOGY; OPTIMIZATION; RADIOTHERAPY;

CONCURRENT CHEMOTHERAPY; DOSE-VOLUME OF PERICARDIUM AND HEART; ESOPHAGEAL CANCER; PERICARDIAL EFFUSION; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY;

HEALTH RISKS;

ANTINEOPLASTIC AGENT; CAPECITABINE; CISPLATIN; ETOPOSIDE; FLUOROURACIL; IRINOTECAN; PACLITAXEL; UFT;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DOSIMETRY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HEART; HEART VOLUME; HISTOGRAM; HUMAN; INOPERABLE CANCER; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; PERICARDIAL EFFUSION; PERICARDIUM; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR; STATISTICAL SIGNIFICANCE; THORAX RADIOGRAPHY; UNIVARIATE ANALYSIS;

AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PERICARDIAL EFFUSION; PERICARDIUM; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RISK FACTORS;

EID: 39049090856     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.10.056     Document Type: Article

References (34)

1. Machtay M., Lee J.H., Stevenson J.P., et al. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: Long-term results and associations with pathologic response. J Thorac Cardiovasc Surg 127 (2004) 108-113
2. Jassem J. Chemoradiotherapy of non-small cell lung cancer. Expert Rev Anticancer Ther 2 (2002) 402-407
3. Wendland M.M., and Sause W.T. Induction chemotherapy followed by radical local therapy for locally advanced non-small cell lung cancer. Semin Surg Oncol 21 (2003) 111-121
4. Gladstone D.J., Flanagan M.F., Southworth J.B., et al. Radiation-induced cardiomyopathy as a function of radiation beam gating to the cardiac cycle. Phys Med Biol 49 (2004) 1475-1484
5. Adams M.J., Lipshultz S.E., Schwartz C., et al. Radiation-associated cardiovascular disease: Manifestations and management. Semin Radiat Oncol 13 (2003) 346-356
6. Lee P.J., and Mallik R. Cardiovascular effects of radiation therapy: Practical approach to radiation therapy-induced heart disease. Cardiol Rev 13 (2005) 80-86
7. Prosnitz R.G., Chen Y.H., and Marks L.B. Cardiac toxicity following thoracic radiation. Semin Oncol 32 Suppl. (2005) S71-S80
8. Marks L.B., Yu X., Prosnitz R.G., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63 (2005) 214-223
9. Seddon B., Cook A., Gothard L., et al. Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy. Radiother Oncol 64 (2002) 53-63
10. Landau D., Adams E.J., Webb S., et al. Cardiac avoidance in breast radiotherapy: A comparison of simple shielding techniques with intensity-modulated radiotherapy. Radiother Oncol 60 (2001) 247-255
11. Hardenbergh P.H., Munley M.T., Bentel G.C., et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: Preliminary results. Int J Radiat Oncol Biol Phys 49 (2001) 1023-1028
12. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355 (2000) 1757-1770
13. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
14. Paszat L.F., Mackillop W.J., Groome P.A., et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the Surveillance, Epidemiology, and End-Results cancer registries. J Clin Oncol 16 (1998) 2625-2631
15. Gyenes G., Rutqvist L.E., Liedberg A., et al. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48 (1998) 185-190
16. Shapiro C.L., Hardenbergh P.H., Gelman R., et al. Cardiac effects of adjuvant doxorubicin and radiation therapy in breast cancer patients. J Clin Oncol 16 (1998) 3493-3501
17. Koontz B.F., Kirkpatrick J.P., Clough R.W., et al. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: Cure balanced against complications. J Clin Oncol 24 (2006) 605-611
18. Moser E.C., Noordijk E.M., van Leeuwen F.E., et al. Long-term risk of cardiovascular disease after treatment for aggressive non-Hodgkin lymphoma. Blood 107 (2006) 2912-2919
19. Adams M.J., Lipsitz S.R., Colan S.D., et al. Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 22 (2004) 3139-3148
20. Reinders J.G., Heijmen B.J., Olofsen-van Acht M.J., et al. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up. Radiother Oncol 51 (1999) 35-42
21. Piovaccari G., Ferretti R.M., Prati F., et al. Cardiac disease after chest irradiation for Hodgkin's disease: Incidence in 108 patients with long follow-up. Int J Cardiol 49 (1995) 39-43
22. Hancock S.L., Tucker M.A., and Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993) 1949-1955
23. Hancock S.L., Donaldson S.S., and Hoppe R.T. Cardiac disease following treatment of Hodgkin's disease in children and adolescents. J Clin Oncol 11 (1993) 1208-1215
24. Cosset J.M., Henry-Amar M., Pellae-Cosset B., et al. Pericarditis and myocardial infarctions after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys 21 (1991) 447-449
25. Martel M.K., Sahijdak W.M., Ten Haken R.K., et al. Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 40 (1998) 155-161
26. Tripp P., Malhotra H.K., Javle M., et al. Cardiac function after chemoradiation for esophageal cancer: Comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes. Dis Esophagus 18 (2005) 400-405
27. ICRU Report 50. Prescribing, recording, and reporting photon beam therapy (1993), International Commission on Radiation Units and Measurements, Bethesda, MD
28. Rodary C., Laplanche A., Comnougue C., et al. Estimation of survival rates: Techniques used. Bull Cancer 66 (1979) 575-580
29. Mantini G., Smaniotto D., Balducci M., et al. Radiation-induced cardiovascular disease: Impact of dose and volume. Rays 30 (2005) 157-168
30. Prosnitz R.G., and Marks L.B. Radiation-induced heart disease: Vigilance is still required. J Clin Oncol 23 (2005) 7391-7394
31. Goethals I., Dierckx R., De Meerleer G., et al. The role of nuclear medicine in the prediction and detection of radiation-associated normal pulmonary and cardiac damage. J Nucl Med 44 (2003) 1531-1539
32. Hancock S.L., and Hoppe R.T. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Semin Radiat Oncol 6 (1996) 225-242
33. Gray H, editor. Gray's anatomy. In: Gabella G, editor. Cardiovascular. 38th ed. New York: Churchill Livingstone; 1995. p. 1471.
34. Moore K., and Dalley A. Clinically oriented anatomy. 5th ed. (2006), Lippincott Williams & Wilkins, Philadelphia p. 137-140